Short answer: the research is real but small — low-dose methylene blue is linked to sharper attention and memory, not proven to make you smarter
Methylene blue is a blue dye with over 100 years of medical use. At low doses it works as an electron carrier in your mitochondria — the parts of your cells that make energy. The maker's dosage guide cites research by Dr. Francisco Gonzalez-Lima at the University of Texas showing that low-dose methylene blue improved sustained attention and memory retrieval in healthy adults, with effects kicking in within 30 to 60 minutes and lasting 4 to 6 hours. But the honest version is this: the studies are small and mostly old, they tested the compound methylene blue — not Meraki Blu as a product — and no large modern trial shows this bottle improves focus in healthy adults. It is a plausible mechanism with suggestive evidence, not a proven brain upgrade.
How we wrote this: we have not hands-on tested Meraki Blu. Prices, doses, and research claims below come from the maker's own product page and dosage guide, as checked on October 31, 2026, and we say so wherever a claim is the maker's rather than our own finding.
Check the current price of Meraki Blu on the maker's site
What methylene blue actually is
Short answer: a synthetic blue dye first used for textiles and malaria, now an FDA-approved prescription drug for one specific condition — and sold as a supplement at far lower doses.
Methylene blue started as a textile dye in the 1870s and became one of the first synthetic drugs, used against malaria. Today the FDA has approved it only as a prescription drug for methemoglobinemia, a blood condition — not as a supplement, and not for focus, energy, or any other everyday use. The supplement version is the same compound at much lower doses: Meraki Blu contains 150 mg in a 30 mL bottle, or 5 mg per mL, about 0.25 mg per drop.
Tim Ferriss put the market in one line on his podcast in March 2026: "120 years of research, zero guardrails." He was talking about the gap between methylene blue's legitimate medical history and the unregulated supplement market selling unknown-quality compounds. That is the right frame for this article: the compound has real history, but the market around it has almost no guardrails, so purity and dose matter more than hype. For the purity checks that matter before buying any bottle, see our original Meraki Blu review.
How it is supposed to work in the brain
Short answer: it shuttles electrons in the mitochondrial electron transport chain, giving cells a direct assist in making ATP — but only at low doses, because at high doses the effect reverses.
The maker's dosage guide explains the mechanism this way: at low concentrations, methylene blue works as an electron carrier, donating electrons to cytochrome c oxidase (Complex IV) in the mitochondria and supporting ATP production. The result, according to the maker, is more cellular energy, better oxygen consumption, and sharper cognitive function. The brain is a plausible target because methylene blue crosses the blood-brain barrier and concentrates in neural tissue, and neurons burn enormous amounts of energy.
The dose-response curve is the part most marketing skips. Methylene blue follows what researchers call a hormetic, or biphasic, curve: at low doses it donates electrons, but at high doses it starts pulling them away and becomes a pro-oxidant, so mitochondria work harder and produce less usable energy. The maker's guide puts it plainly: more is not better with methylene blue. Better is better.
What the research actually shows — and what it does not
Short answer: small, mostly old studies link low-dose methylene blue to better attention, memory, and brain metabolism — but none of them tested Meraki Blu, and the evidence is suggestive, not settled.
The research the maker cites is real, and it is worth naming honestly. Gonzalez-Lima's research on healthy adults showed improved sustained attention and memory retrieval at low oral doses. The maker's homepage also cites clinical trials showing significant improvements in cognitive function, energy levels, and cellular health with regular use — referencing Narsapur and Naylor (1983) and Naylor and colleagues (1986). Those are 1980s studies, small by modern standards, and they tested methylene blue as a compound, not this product.
Two numbers on the maker's homepage need the same honest reading. The site says its claims are backed by 18,000+ studies — that counts studies of methylene blue as a compound across more than a century, not trials of Meraki Blu and not trials of low-dose supplementation for focus. And the homepage lists 89% of users feeling enhanced clarity and focus, 91% better mood, and 93% compounding benefits over time, with a footnote that those figures are based on peer-reviewed methylene blue studies and Meraki customer feedback. A blend of studies plus customer feedback is not a measured outcome for this product, so treat those percentages as marketing, not results.
One more distinction the maker's own guide makes, and it matters: clinical research typically uses 0.5 to 2 mg per kilogram of body weight, which is 35 to 140 mg for a 154-pound person. Those are not supplement doses. The guide warns directly not to use clinical research dosing as a guide for daily supplementation.
The dose that matters for focus
Short answer: for focus, the maker's guide points to 1 to 5 mg a day — 4 to 20 drops — taken in the morning on an empty stomach, with effects in 30 to 60 minutes lasting 4 to 6 hours.
The maker's dosage guide gives a range by goal. For cognitive enhancement and focus it lists 1 to 5 mg (4 to 20 drops) as the best-studied range for brain performance, taken in the morning, with cognitive effects typically kicking in within 30 to 60 minutes and lasting 4 to 6 hours. For daily energy and mitochondrial support it lists 5 to 10 mg (20 to 40 drops). The standard dose most customers report is about 20 drops, or about 5 mg, a day — the guide says 90% of customers report 5 mg as their daily dose.
Start low regardless of body weight, according to the guide: 1 to 3 drops (0.25 to 0.75 mg) for the first three days, then build up by a few drops every few days. Take it on an empty stomach and wait 20 to 30 minutes before eating, because absorption improves without food competing in the gut. Morning dosing is strongly preferred — the guide says methylene blue has a mild stimulatory effect on brain metabolism, so taking it after 2 PM may affect sleep. Some people cycle, 5 days on and 2 days off, or 4 weeks on and 1 week off, to maintain sensitivity. Never exceed 60 drops (15 mg) a day without professional guidance.
See Meraki Blu's current price on the maker's site
For the full cost of each of those doses, see our Meraki Blu price-per-dose breakdown.
What it does not do
Short answer: it does not treat ADHD, depression, dementia, or any disease — and feeling sharper for a few hours is not the same as a lasting cognitive gain.
This is where the focus conversation usually goes wrong. Nothing in the research shows methylene blue treats attention deficit disorders, depression, Alzheimer's disease, or any other condition, and Meraki Blu's own product page states plainly that it is not intended to diagnose, treat, cure, or prevent any disease. A morning lift in clarity, if you feel one, is a short effect — 4 to 6 hours, according to the maker's guide — not a permanent change in how your brain works.
Customer reviews are not evidence either. The maker's site lists over 10,000 reviews, rated 4.47 out of 5, with buyers reporting sharper focus and less brain fog within minutes. Those are self-selected reports on the seller's own page, and they cannot tell you whether you will feel anything, or whether what people feel is the compound, the morning ritual, or the expectation of both. And the blue side effects are real: your tongue turns blue for an hour or two, your urine turns blue-green, and at higher doses even sweat can carry a faint blue tint. The dye also stains — teeth, clothes, and surfaces — so the maker suggests mixing it with water or juice and using a straw.
The safety section: read this before anything else
Short answer: methylene blue is a potent MAOI with serious drug interactions, it is prohibited for US service members without a prescription, and it is not for everyone.
This section is not optional, and it comes before any decision to buy. The US Department of Defense's Operation Supplement Safety (OPSS) posted on October 8, 2026 that methylene blue is on the DoD Prohibited Dietary Supplement Ingredients List — prohibited for service members without a prescription, and the safety of non-prescription products sold online is not guaranteed. The FDA has approved methylene blue only as a prescription drug for methemoglobinemia, not as a supplement.
The most serious risk is the drug interaction. Methylene blue is a potent monoamine oxidase inhibitor (MAOI). Combined with serotonergic drugs — SSRIs, SNRIs, MAOIs, opioids, or dextromethorphan — it can trigger serotonin syndrome: agitation, rapid heart rate, high blood pressure, high temperature, and in severe cases seizures. The FDA has issued a specific warning about this interaction, and the maker's own dosage guide repeats it in full: do not take methylene blue with any serotonergic medication without direct guidance from your prescribing physician. The guide also warns against combining it with serotonergic supplements such as St. John's Wort and 5-HTP.
Other risks from the maker's own guidance: methylene blue can trigger hemolysis in people with G6PD deficiency, so get tested if you have the condition or are not sure. It is not for use in pregnancy or breastfeeding — there is not enough safety data. It can inhibit certain cytochrome P450 pathways, changing how other drugs are metabolized. It can increase skin sensitivity to UV light. And it is a powerful dye: temporary blue-green tongue and urine, and permanent staining of anything it touches.
If you take any prescription drug, have G6PD deficiency, or are pregnant or breastfeeding, talk to a clinician first — and bring the bottle to the appointment, as the maker's guide itself suggests.
This article is general information only, not medical advice.
Frequently asked questions
Does methylene blue actually improve focus?
Low-dose research links it to better sustained attention and memory retrieval in healthy adults, according to the maker's dosage guide citing Gonzalez-Lima's work. But the studies are small and old, they tested the compound — not Meraki Blu — and no large modern trial proves this bottle improves focus. Treat it as suggestive evidence, not a guarantee.
How long does it take to feel anything?
According to the maker's guide, cognitive effects typically kick in within 30 to 60 minutes and last 4 to 6 hours. Broader mitochondrial support may take 1 to 2 weeks of consistent use to become noticeable. We have not hands-on tested it, so we cannot confirm the effect for any individual.
What dose is used for focus?
The maker's guide lists 1 to 5 mg a day (4 to 20 drops) for cognitive enhancement, starting at 1 to 3 drops and building up slowly. Never exceed 60 drops (15 mg) a day without professional guidance.
Can I take it with antidepressants?
Do not combine methylene blue with SSRIs, SNRIs, MAOIs, or any drug that affects serotonin without direct guidance from your prescribing physician. The combination can trigger serotonin syndrome, and the FDA has issued a specific warning about it.
Verdict: interesting science, unproven product
If you are drawn to the mechanism — a mitochondrial electron carrier with low-dose research behind it — Meraki Blu is a well-documented way to try it, with a published certificate of analysis and a clear per-drop dose. But buy it for the experiment, not for a promised result: the evidence is small and old, the focus effects are short-lived, and the safety screen is serious. Check every interaction first, start at 1 to 3 drops, and do not spend on bundles until you know whether you feel anything at all.
